Status Epilepticus clinical trials

Explore recruiting status epilepticus clinical trials.

Recruiting status epilepticus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Status Epilepticus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of ELectroencephalographic STatus epilepticus After cardiopulmonary Resuscitation-2 (TELSTAR-2): a multicenter randomised clinical trial and health economic evaluation of anti-seizure treatment in comatose cardiac arrest patients with status epilepticus on continuous EEG.

Belgium, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment of Established Status Epilepticus in the Elderly - a prospective, randomized, double-blind comparative effectiveness trial

Germany

Therapeutic use (Phase IV) EU CTIS Study details

FAST ACUTE SEDATION AT INTENSIVE CARE VS. HIGH-DOSE I.V. ANTI-SEIZURE MEDICATION FOR TREATMENT OF NON-CONVULSIVE STATUS EPILEPTICUS - A RANDOMIZED, MULTICENTER TRIAL (FAST TRIAL)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of intravenous ganaxolone added to standard of care in refractory status epilepticus

Austria, Denmark, France, Lithuania, Germany, Finland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Study of Oral MC-1 for the Treatment of Patients with PNPO Deficiency

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of probenecid on cluster seizures during dosage reduction of Anti Seizure Medication (ASM) in presurgical focal epilepsy video-EEG monitoring

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Status Epilepticus trials by city

Status Epilepticus in Toronto Status Epilepticus in Vancouver Status Epilepticus in Montreal Status Epilepticus in Calgary Status Epilepticus in Edmonton Status Epilepticus in Ottawa Status Epilepticus in Winnipeg Status Epilepticus in Quebec City Status Epilepticus in Hamilton Status Epilepticus in Kitchener Status Epilepticus in London Status Epilepticus in Halifax Status Epilepticus in New York Status Epilepticus in Los Angeles Status Epilepticus in Chicago Status Epilepticus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease